M. Weck

发表

Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle

G. Mayr, M. Jücker, E. Endl, 2004, Leukemia.

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.

A. Bringmann, P. Brossart, M. Weck, 2004, Blood.

CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells.

S. Moutel, P. Brossart, M. Weck, 2004, Blood.

Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes

H. Rammensee, S. Stevanović, P. Brossart, 2004, Clinical Cancer Research.

hDectin-1 is involved in uptake and cross-presentation of cellular antigens.

A. Bringmann, P. Brossart, M. Weck, 2008, Blood.

Molecular and functional characterization of human Dectin-1.

P. Brossart, M. Weck, F. Grünebach, 2002, Experimental hematology.

Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes

P. Brossart, M. Weck, S. Appel, 2005, Cancer Gene Therapy.

TLR ligands differentially affect uptake and presentation of cellular antigens.

A. Bringmann, P. Brossart, M. Weck, 2007, Blood.

PPAR-agonists inhibit toll-like receptor – mediated activation of dendritic cells via the MAP kinase and NF-B pathways

A. Bringmann, M. Weck, S. Appel, 2005 .

Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells

A. Bringmann, P. Brossart, M. Weck, 2007, Leukemia.

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

A. Heine, P. Brossart, M. Weck, 2005, Blood.

Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells

T. Holderried, A. Heine, A. Bringmann, 2009, Leukemia.

Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-κB and Akt Signaling Pathways

O. Schoor, T. Brümmendorf, P. Brossart, 2005, Clinical Cancer Research.

Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs.

A. Bringmann, P. Brossart, M. Weck, 2006, Blood.

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.

T. Holderried, A. Heine, P. Brossart, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

T. Brümmendorf, A. Boehmler, L. Kanz, 2004, Blood.

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

L. Kanz, P. Brossart, M. Weck, 2003, Blood.

Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

H. Rammensee, S. Stevanović, O. Schoor, 2004, Cancer Research.